Encompass Health EVP granted 10,502 stock options

Encompass Health Corp executive Patrick William Tuer reported two equity-related transactions.

Accepted by SEC EDGAR 03/03/2026 - 12:08 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Encompass Health Corp executive Patrick William Tuer reported two equity-related transactions. He received a grant of 10,502 non-qualified stock options at an exercise price of $108.06 per share, which become exercisable in three equal annual installments starting on March 2, 2027. Separately, 545 shares of common stock at $107.88 per share were withheld to cover tax obligations arising from the vesting of related restricted stock, leaving him with 25,437 directly held shares.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Tuer Patrick William

Role EVP, Chief Operating Officer

Type	Security	Shares	Price	Value
Grant/Award	Non-qualified Stock Option (Right to Buy)	10,502	$108.06	$1.13M
Exercise Price or Tax Liability	Encompass Health Common Stock	545	$107.88	$59K

Holdings After Transaction: Non-qualified Stock Option (Right to Buy) — 10,502 contracts (Direct); Encompass Health Common Stock — 25,437 shares (Direct)

Holdings Before and After: Non-qualified Stock Option (Right to Buy), 0 to 10,502 contracts (Direct); Encompass Health Common Stock, 25,982 to 25,437 shares (Direct)

Footnotes (2)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.
2. F2. The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) executive Patrick William Tuer report on this Form 4?

Patrick William Tuer reported an option grant and a tax-related share withholding. He received 10,502 non-qualified stock options and had 545 common shares withheld to cover tax obligations from restricted stock vesting.

How many stock options did Patrick William Tuer receive from Encompass Health (EHC)?

He received 10,502 non-qualified stock options with an exercise price of $108.06 per share. These options are part of his equity compensation and vest over time according to a defined schedule.

When do Patrick William Tuer’s newly granted Encompass Health (EHC) options vest?

The options become exercisable in three equal annual installments starting March 2, 2027. This means one-third of the grant vests each year over a three-year period, aligning with longer-term service and performance.

Why were 545 Encompass Health (EHC) shares disposed of in this Form 4?

The 545 shares were withheld to satisfy tax withholding obligations tied to vesting restricted stock. This is a tax-withholding disposition, not an open-market sale, and is a common mechanism in equity compensation plans.

How many Encompass Health (EHC) shares does Patrick William Tuer hold after these transactions?

After the reported transactions, he directly holds 25,437 shares of Encompass Health common stock. This figure reflects his position following the tax-related share withholding connected to restricted stock vesting.

Was there an open-market buy or sell of Encompass Health (EHC) shares by Patrick William Tuer?

No open-market buy or sell is reported. The Form 4 shows an option grant and a tax-withholding disposition, where 545 shares were withheld to cover tax obligations from vesting restricted stock rather than sold on the market.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Tuer Patrick William

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, Chief Operating Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/28/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/28/2026		F		545(1)	D	$107.88	25,437	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-qualified Stock Option (Right to Buy)	$108.06	03/02/2026		A		10,502		03/02/2027(2)	03/02/2036	Encompass Health Common Stock	10,502	$108.06	10,502	D

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

2. The option becomes exercisable in equal annual installments over a three-year period commencing March 2, 2027.

	/s/ Patrick Darby, attorney-in-fact for Patrick W. Tuer	03/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.